Trial Profile
A Phase I trial of SAR438335 for the treatment of Type 2 Diabetes
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 07 May 2018
Price :
$35
*
At a glance
- Drugs SAR 438335 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 07 May 2018 New trial record